By Denny Jacob
Amneal Pharmaceuticals on Monday said it received abbreviated new drug application approvals from the U.S. Food and Drug Administration for some complex generic products.
The drug company said the approvals pertain to Medroxyprogesterone acetate injectable suspension, a generic version of Depo-Provera, and Dexmedetomidine Hydrochloride,…
Read the full article here